Neuropsychiatric Adverse Effects of Antiparkinsonian Drugs

“Mini-mental state”

1975 • 82,784 citations

Normative data on a battery of neuropsychological tests in the Han Chinese population

2010 • 20,181 citations

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

2013 • 20,010 citations

Older Adults' Reasons for Using Technology while Aging in Place

2015 • 19,091 citations

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

2014 • 18,386 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

‘FRONTAL’ COGNITIVE FUNCTION IN PATIENTS WITH PARKINSON'S DISEASE ‘ON’AND ‘OFF’ LEVODOPA

1988 • 844 citations

Parkinson’s Disease and Movement Disorders

2005 • 811 citations

Amantadine in the Treatment of Parkinson's Disease

1969 • 599 citations

Risk factors for nursing home placement in advanced Parkinson's disease

1993 • 444 citations

The Mechanism of Action of Novel Antipsychotic Drugs

1991 • 410 citations

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa

1996 • 353 citations

The effect of deprenyl and levodopa on the progression of Parkinson's disease

1995 • 324 citations

Levodopa-induced psychosis: a kindling phenomenon

1978 • 316 citations

Anxiety disorders in patients with Parkinson's disease

1990 • 291 citations

Mortality and hallucinations in nursing home patients with advanced Parkinson's disease

1995 • 282 citations

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1989 • 256 citations

Hypersexuality with Antiparkinsonian Therapy

1989 • 217 citations

Polysomnographic sleep measures in Parkinson's disease patients with treatment‐induced hallucinations

1993 • 209 citations

Parkinson's disease: drug-induced psychiatric states.

1995 • 202 citations

Psychosis in advanced Parkinson's disease

1995 • 193 citations

A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease

1994 • 186 citations

Psychosis and Other Psychiatric Manifestations of Levodopa Therapy

1970 • 171 citations

Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.

1988 • 169 citations

Behavioral Complications of Drug Treatment of Parkinson's Disease

1991 • 166 citations

Therapy of Parkinson's Disease

1990 • 158 citations

Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.

1995 • 157 citations

Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis

1990 • 150 citations

Clozapine in the treatment of psychosis in Parkinson's disease

1989 • 148 citations

"Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.

1993 • 145 citations

Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease

1987 • 139 citations

TREATMENT OF PARKINSONISM WITH BROMOCRIPTINE

1974 • 137 citations

Confusion, dementia and anticholinergics in Parkinson's disease.

1982 • 134 citations

Amantadine in Parkinson's Disease

1972 • 133 citations

MENTAL SYMPTOMS IN PARKINSONIAN PATIENTS TREATED WITH L-DOPA

1970 • 129 citations

Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluperlapine

1985 • 127 citations

ECT and Parkinson's disease revisited: a "naturalistic" study

1989 • 126 citations

Cholinergic deficiency and frontal dysfunction in Parkinson's disease

1990 • 125 citations

Pharmacology of hallucinations induced by long-term drug therapy

1982 • 124 citations

Treatment of Parkinson's Disease with Bromocriptine

1976 • 123 citations

Akathisia in idiopahic Parkinson's disease

1987 • 115 citations

Pharmacologic Treatment of Parkinsonian Tremor

1986 • 111 citations

Clozapine‐responsive tremor in Parkinson's disease

1990 • 105 citations

Comparison of pergolide and bromocriptine therapy in parkinsonism

1983 • 101 citations

Drug holiday and management of Parkinson disease

1980 • 98 citations

Pergolide in the treatment of Parkinson's disease

1995 • 97 citations

The Management of the Levodopa Psychoses

1991 • 96 citations

Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)

1975 • 95 citations

Clozapine prevents recurrence of psychosis in Parkinson's disease

1992 • 94 citations

Clozapine

1994 • 93 citations

Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease.

1993 • 92 citations

SUBCUTANEOUS LISURIDE INFUSION IN PARKINSON'S DISEASE

1991 • 90 citations

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings

1995 • 85 citations

Sleep in Parkinson's Disease

1995 • 82 citations

Bromocriptine in Parkinson disease.

1985 • 80 citations

Clozapine for psychosis in Parkinson's disease

1990 • 79 citations

Low-dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease

1995 • 78 citations

Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reduction

1994 • 78 citations

Symptomatic effect of selegiline in de novo parkinsonian patients

1993 • 77 citations

Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study

1994 • 75 citations

AMANTADINE DOSAGE IN TREATMENT OF PARKINSON'S DISEASE

1970 • 74 citations

Cognitive Processes in Idiopathic Dystonia Treated with High-Dose Anticholinergic Therapy

1991 • 70 citations

ECT-induced delirium in depressed patients with Parkinson's disease

1991 • 70 citations

Behavioral Neurology of Movement Disorders

1995 • 70 citations

Treatment of drug-induced psychosis in Parkinson's disease with clozapine.

1993 • 69 citations

Treatment of Parkinson's Disease with Electroconvulsive Therapy

1991 • 68 citations

Low dosages of bromocriptine added to levodopa in Parkinson's disease

1985 • 66 citations

Responsibility of extrastriatal areas for the appearance of psychotic symptoms (Clinical and biochemical human post-mortem findings)

1975 • 66 citations

Comparative study of selegiline plus <scp>L</scp>‐dopa–carbidopa versus <scp>L</scp>‐dopa–carbidopa alone in the treatment of parkinson's disease

1995 • 66 citations

Akathisia in Parkinson's disease

1994 • 65 citations

Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities

2009 • 63 citations

Levodopa's awakening effect on patients with Parkinsonism

1971 • 62 citations

Disturbance of Recent Memory Function in Parkinsonian Patients on Anticholinergic Therapy

1984 • 61 citations

Psychotic complications of long-term levodopa treatment of Parkinson's disease

1991 • 61 citations

Treatment of Dopaminomimetic Psychosis in Parkinson's Disease with Electroconvulsive Therapy

1988 • 61 citations

Deprenyl as Symptomatic Therapy in Parkinsonʼs Disease

1988 • 58 citations

Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs

1995 • 56 citations

Plasma Clozapine Levels and the Treatment of L-DOPA-Induced Psychosis in Parkinson's Disease A High Potency Effect of Clozapine

1995 • 56 citations

Psychiatric complications of levodopa therapy of Parkinson's disease.

1984 • 56 citations

Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers

1987 • 54 citations

Four‐year treatment of patients with parkinsonism using amantadine alone or with levodopa

1978 • 53 citations

Use of Amantadine in Parkinson's Disease. Results of a Double-blind Trial

1970 • 50 citations

Amantadine and Motor Fluctuations in Chronic Parkinsonʼs Disease

1987 • 49 citations

Extrapyramidal reaction to ondansetron

1992 • 47 citations

Apomorphine and lisuride infusion. A comparative chronic study.

1993 • 45 citations

A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease

1995 • 44 citations

Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome

1993 • 44 citations

Trihexyphenidyl (Artane) Abuse: Euphoriant and Anxiolytic

1982 • 43 citations

Clozapine Treatment of Parkinsonism with Psychosis

1993 • 42 citations

Is L‐DOPA drug holiday useful?

1980 • 41 citations

Clozapine treatment of psychosis in Parkinson's disease

1989 • 41 citations

Fluctuations in plasma dopamine level impair memory in Parkinson's disease

1987 • 39 citations

Effects of Biperiden and Amantadine on Memory in Medicated Chronic Schizophrenic Patients

1995 • 39 citations

Mental Symptoms in Parkinsonism following Benzhexol Hydrochloride Therapy

1956 • 39 citations

TREATMENT OF PARALYSIS AGITANS WITH ORPHENADRINE (DISIPAL) HYDROCHLORIDE

1957 • 38 citations

Deprenyl versus placebo in Parkinson disease: a double-blind study.

1987 • 36 citations

Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)

1983 • 36 citations

Early combination therapy with bromocriptine and levodopa in parkinson's disease

1993 • 36 citations

Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine

1982 • 36 citations

The Role of l-DOPA Holiday in the Long-Term Management of Parkinsonʼs Disease

1986 • 36 citations

Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease

1973 • 36 citations

Pseudo‐phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline

1995 • 35 citations

Late cognitive changes in Parkinson's disease with an emphasis on dementia.

1995 • 35 citations

Coloured Lilliputian Hallucinations with Amantadine

1973 • 34 citations

Mania Secondary to Procyclidine (‘Kemadrin’) Abuse

1982 • 33 citations

Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease

1992 • 33 citations

A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease

1972 • 32 citations

Apomorphine for Motor Fluctuations and Freezing in Parkinson's Disease

1995 • 32 citations

Selegiline in the treatment of daily fluctuations in disability of parkinsonian patients with long-term levodopa treatment

1989 • 30 citations

Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy

1993 • 29 citations

Effects of Selegiline (Deprenyl) on Cognition in Early Parkinsonʼs Disease

1995 • 27 citations

Electroconvulsive therapy and Parkinson's disease: the case for further study.

1994 • 27 citations

Reversible Pathologic Jealousy (Othello Syndrome) Associated With Amantadine

1991 • 26 citations

FIVE-YEAR STUDY OF BENZTROPINE (COGENTIN) METHANESULFONATE

1956 • 24 citations

Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy.

1975 • 24 citations

The adverse effect of benzhexol on memory in Parkinson's disease

1987 • 23 citations

Hallucinations in Parkinson's disease: Characteristics and associated clinical features

1995 • 23 citations

Amantadine in Senile Dementia: Electroencephalographic and Clinical Effects

1979 • 20 citations

International guide to drugs for Parkinson's disease

1995 • 20 citations

Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

1971 • 18 citations

Intermittent subcutaneous apomorphine injection treatment for Parkinsonian motor oscillations

1991 • 18 citations

Anwesenheit: Psychopathology and Clinical Associations

1982 • 18 citations

Pergolide therapy for Parkinson's disease

1984 • 16 citations

Double-blind, crossover placebo controlled trial of selegiline in Parkinson's disease - an interim analysis

1989 • 15 citations

An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group.

1989 • 15 citations

Adverse Reactions to Controlled Release Levodopa/Carbidopa in Older Persons: Case Reports

1995 • 13 citations

Symptomatic relief from treatment‐induced psychosis in Parkinson's disease: An open‐label pilot study with remoxipride

1994 • 13 citations

Pergolide mesylate: four years experience in Parkinson's disease.

1987 • 13 citations

Remoxipride in Parkinsonʼs Disease

1995 • 12 citations

Levodopa and orphenadrine hydrochloride in parkinsonism

1971 • 10 citations

Pergolide and lisuride in advanced Parkinson's disease.

1984 • 10 citations

On the synchronizing effect of amantadine-1-hydrochlorid (symmetrel) on pathological EEG-activity

1975 • 8 citations

Pergolide in the treatment of Parkinson's disease.

1984 • 6 citations

Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.

1987 • 4 citations

Zotepine in levodopa‐induced psychosis

1995 • 4 citations